NEW YORK, Feb. 9, 2016 /PRNewswire-HISPANIC PR WIRE/ — The Vilcek Foundation is proud to announce Fernando Camargo and Roberta Capp as winners of the 2016 Vilcek Prize for Creative Promise in Biomedical Science. The prizes honor young immigrants who have demonstrated exceptional early accomplishment, and whose careers contribute to the American arts and sciences. Each prize includes a $50,000 cash award.

Fernando Camargo is an associate professor at Boston Children’s Hospital and Harvard Medical School. Camargo’s work has led to major technical advances in researchers’ ability to track circulating blood and immune cells and uncovered surprising insights into their origins. Contrary to a long-held view that blood cells arise from so-called hematopoietic stem cells, Camargo showed that a different group of primitive cells called progenitor cells give rise to circulating blood cells. Because progenitor cells are more abundant than hematopoietic stem cells and also long-lived, the findings bear implications for improving the efficacy of blood transplantation in the clinic. Camargo has also unraveled the role of a cellular signaling protein called Yap1, which controls cell growth and organ size. He is working on developing ways to boost or suppress Yap1 in cells for an array of clinical applications, including cancer treatment and regenerative medicine. Camargo was born in Arequipa, Peru.

Roberta Capp is an assistant professor at the University of Colorado School of Medicine. Capp’s efforts to solve problems that plague access to health care in the United States have led to insights on emergency department use by Medicaid enrollees. Capp found that many patients on Medicaid often depend on emergency departments for non-urgent conditions best treated in primary care settings, largely due to systemic barriers to primary care. To address the issue, Capp conducted a randomized controlled trial of a program of patient navigators, a term applied to trained professionals who work closely with patients to help them obtain timely primary care from diagnosis to follow-up. The trial revealed that patient navigation services made a significant dent in emergency-department use and hospital admissions. Capp is now working with Medicaid officials in Colorado to find ways to improve health care access and delivery for underserved communities. She is also exploring ways to reduce return visits to emergency departments that are attributed to medical errors. Her work has implications for making health care accessible, affordable, and patient-centered. Capp was born in São Paulo, Brazil.

In addition to prizes in biomedical science, the Vilcek Foundation also recognized immigrants in the arts with the 2016 Vilcek Prizes in Theatre.

To learn more about the Vilcek Foundation and the Vilcek Prizes, please visit Vilcek.org.

Photo – http://photos.prnewswire.com/prnh/20160209/331231

KENILWORTH, New Jersey, Feb. 9, 2016 /PRNewswire-HISPANIC PR WIRE/ — Merck Manuals* is proud to announce the 116-year-old trusted medical resource is now available in Spanish on MerckManuals.com in the United States.

The U.S. is now the second largest Spanish-speaking country in the world, behind only Mexico. Despite this growth, the proportion of Spanish-speaking doctors has declined steadily over the last 30 years, and professionally translated medical information for Spanish speakers remains limited. Poor translation quality of online resources is another barrier to accessing reliable medical information.

The Manuals’ more than 10,000 medical resources, including articles, educational quizzes, how-to videos and medical calculators, were translated into Spanish through a multi-step process, using highly qualified native Spanish-speaking doctors and medical linguists. The Manuals then hired independent, native Spanish-speaking physician reviewers to examine select pieces of content to ensure the quality of the translation.

MerckManuals.com features a unique toggle function that allows users to easily switch between professional and consumer versions and their Spanish translations. With the click of a mouse, physicians can toggle to the consumer version of the site and then access the Spanish translation, providing patients with trusted medical information in layman’s terms in their native language, ultimately improving communication between doctors and patients.

“Researching medical issues online should not cause more anxiety than clarification,” said Robert Porter, M.D., Editor-in-Chief of The Merck Manuals and one of the United States’ preeminent publishing physicians. “For individuals who need medical information in Spanish, an automated translation isn’t good enough. In fact, a poor translation could be a significant barrier to an effective relationship between patients and health professionals. Here’s an example: Doctors often prescribe medication to be taken ‘once’ daily. In Spanish, ‘once’ translates to the number 11. A computer may not catch something like that, which poses a significant risk to patients who think they’re following doctors’ directions.”

Since 1899, The Merck Manuals has worked to break down barriers in medical communication – not for profit, but as a public service to improve individuals’ ability to exercise their universal right to credible medical information. Authored by 350 medical experts editorially independent of Merck, The Manuals transitioned to an all-digital format in 2015, available at no cost with no registration or advertisements.

“The best medical information worldwide is documented in English as a universal language, but unfortunately the advances in diagnosis and treatments for common medical conditions are out of reach for all the people around the world who don’t speak English,” said Hector Gonzalez Usigli, M.D., based in Guadalajara, Mexico and Merck Manuals author. “Having a resource translated into their native language is highly important to help increase their medical knowledge, which could make a difference between health and disease for families and entire communities.”

The Spanish translation is a crucial next step in Merck Manuals’ Global Medical Knowledge 2020 Initiative, which is dedicated to making the best current medical information accessible to nearly three billion consumers and health care professionals by 2020.

*The Merck Manuals are known as MSD Manuals outside of the United States and Canada. MSDManuals.com is also now available in Spanish.

About The Merck Manuals and MSD Manuals

First published in 1899 as a small reference book for physicians and pharmacists, The Merck Manual grew in size and scope to become one of the world’s most widely used comprehensive medical resources for professionals and consumers. As The Manual evolved, it continually expanded the reach and depth of its offerings to reflect the mission of providing the best medical information to a wide cross-section of users, including medical professionals and students, veterinarians and veterinary students, and consumers. In 2015, The Merck Manual and MSD Manual kicked off Global Medical Knowledge 2020, a program to make the best current medical information accessible by up to three billion professionals and patients around the world by 2020. For access to thousands of medical topics with images, videos and a constantly expanding set of resources, visit MerckManuals.com or MSDManuals.com and connect with us on social media: 

For Consumers in the U.S. and its territories: Twitter and Facebook
For Professionals in the U.S. and its territories: Twitter and Facebook

About Merck

Today’s Merck is a global health care leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. For more information, visit www.merck.com and connect with us on Twitter, Facebook, YouTube and LinkedIn.

Forward-Looking Statement of Merck & Co., Inc., Kenilworth, NJ, USA

This news release of Merck & Co., Inc., Kenilworth, NJ, USA (the “Company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the Company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the Company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the Company’s 2014 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

Photo – http://photos.prnewswire.com/prnh/20160205/330181